1. Emerging Roles of Wild-type and Mutant IDH1 in Growth, Metabolism and Therapeutics of Glioma
    Matthew Garrett et al, 2021, Gliomas CrossRef
  2. Glioblastoma Primary Cells Retain the Most Copy Number Alterations That Predict Poor Survival in Glioma Patients
    Chia-Hua Chen et al, 2021, Frontiers in Oncology CrossRef
  3. Cell cultures in assessing radioresistance of glioblastomas
    A.S. Belyashova et al, 2022, Voprosy neirokhirurgii imeni N.N. Burdenko CrossRef
  4. Radioresistance in Glioblastoma and the Development of Radiosensitizers
    Md Yousuf Ali et al, 2020, Cancers CrossRef
  5. RUNX1 and REXO2 are associated with the heterogeneity and prognosis of IDH wild type lower grade glioma
    Haiwei Wang et al, 2021, Scientific Reports CrossRef
  6. Metabolic Rewiring in Radiation Oncology Toward Improving the Therapeutic Ratio
    Marike W. van Gisbergen et al, 2021, Frontiers in Oncology CrossRef

  7. Emerging Roles and Therapeutic Interventions of Aerobic Glycolysis in Glioma


    Wei Han et al, 2020, OncoTargets and Therapy CrossRef